Login / Signup

"Prompt" for PREEMPT: Dotting the I's and Crossing the T's With Ultrasound.

Ahmad Jasem AbdulsalamPelin AnalayMurat KaraAhmed Amine El OumriLevent Özçakar
Published in: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine (2024)
The management of chronic migraine (CM) underwent a significant shift with the introduction of onabotulinumtoxin A (BoNT-A) injections following the landmark PREEMPT trial in 2010. Despite its efficacy, the existing injection protocol lacks precision, prompting a call for revision in light of modern ultrasound (US)-guided techniques. This article highlights the potential of US-guided injections to enhance accuracy, safety, and efficacy in CM treatment. By providing real-time visualization and addressing anatomical variations, US guidance offers a promising avenue for optimizing BoNT-A delivery, minimizing adverse effects, and ensuring therapeutic success.
Keyphrases